[1] Turner D et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in IBD (STRIDE) Initiative of the Inter- national Organization for the Study of IBD (IOIBD): Determi- ning Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021; 160:1570-83.

[2] Buisson A et al. Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with IBD. Inflamm Bowel Dis 2017; 23:1425-33.

[3] Maréchal C et al. Compliance with the faecal calprotec- tin test in patients with IBD. UnitedEuropean Gastroenterol J 2017; 5:702-7.

[4] Maaser C et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019; 13:144-164.

[5] Allocca M et al. Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in UC: a Prospective Study. J Crohns Colitis 2018; 12:1385-91.

[6] Allocca M et al. Comparative Accuracy of Bowel Ultra- sound Versus MagneticResonance Enterography in Combination With Colonoscopy in Assessing Crohn’s Disease and Guiding Clinical Decision-making. J Crohns Colitis 2018; 12:1280-7.

[7] Allocca M et al. Milan ultrasound criteria are accurate in assessing disease activity in UC: external validation. UEG J 2021; 9:438-42.

[8] Dragoni G et al. Correlation of ultrasound scores with en- doscopic activity in Crohn’s disease: a prospective explora- tory study. J Crohns Colitis2023; jjad068. doi:10.1093/ecco- jcc/jjad068.

[9] Rispo A et al. Diagnostic Accuracy of Ultrasonography in theDetection of Postsurgical Recurrence in Crohn’sDisease: A Systematic Review with Meta-analysis. Inflamm Bowel Dis 2018; 24:977-88.

[10] Maaser C et al. Intestinal ultrasound for monitoring the- rapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut 2020; 69:1629-36.

[11] Kucharzik T et al. Use of Intestinal Ultrasound to Moni- tor Crohn’sDisease Activity. ClinGastroenterol Hepatol 2017; 15:535-542.